Love yogurt? Have it in plenty as higher consumption of low-fat fermented dairy products can reduce the risk of developing type 2 diabetes. Scientists at the University of Cambridge found that higher consumption of yoghurt, compared with no consumption, can reduce the risk of...
Hate milk? Opt for these milk-free sources of the bone builder — calcium Milk and milk-products are considered to be a rich source of calcium. But what do you do if you are not too fond of it, and more so, if you are lactose intolerant? Not many of us know this, but there are there are certain foods...
LOHATA, India (AP) — This cluster of poor villages, long known for its colorful silk saris, now is known for something else: tuberculosis. Nearly half of Lohata's population has it — some 100,000 people — and the community's weaving tradition is part of the reason it is on the front line of...
VERNON HILLS, Ill.--(BUSINESS WIRE)--Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced today that Jeffrey Bernstein, President and CEO, and Barry Hollingsworth, CFO will present at the RBC Capital Markets 2014 Healthcare...
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that BSD's exclusive Taiwan distributor, Linden Bioscience Co., Ltd., (Linden) has informed...
WASHINGTON--(BUSINESS WIRE)--The National Committee for Quality Assurance (NCQA) today announced that HealthPoint Medical Group of Tampa, FL is the first practice to receive NCQA Patient-Centered Specialty Practice (PCSP) Recognition. HealthPoint Medical Group, an oncology/hematology practice,...
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be...
